Business Description
Abbott Laboratories
NAICS : 339112
SIC : 3841
ISIN : US0028241000
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | 1.56 | |||||
Interest Coverage | 11.66 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.98 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year EBITDA Growth Rate | 6.8 | |||||
3-Year EPS without NRI Growth Rate | 21.3 | |||||
3-Year FCF Growth Rate | -3.4 | |||||
3-Year Book Growth Rate | 6.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 8.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.7 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.16 | |||||
9-Day RSI | 39.91 | |||||
14-Day RSI | 40.21 | |||||
6-1 Month Momentum % | 16.88 | |||||
12-1 Month Momentum % | 4.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.64 | |||||
Quick Ratio | 1.16 | |||||
Cash Ratio | 0.53 | |||||
Days Inventory | 132.79 | |||||
Days Sales Outstanding | 56.98 | |||||
Days Payable | 85.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.97 | |||||
Dividend Payout Ratio | 0.47 | |||||
3-Year Dividend Growth Rate | 12.3 | |||||
Forward Dividend Yield % | 2.07 | |||||
5-Year Yield-on-Cost % | 3.68 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 3.05 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.1 | |||||
Operating Margin % | 15.76 | |||||
Net Margin % | 13.96 | |||||
FCF Margin % | 12.56 | |||||
ROE % | 15.06 | |||||
ROA % | 7.67 | |||||
ROIC % | 10.41 | |||||
ROC (Joel Greenblatt) % | 70.05 | |||||
ROCE % | 11.98 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.29 | |||||
Forward PE Ratio | 23.04 | |||||
PE Ratio without NRI | 24.34 | |||||
Shiller PE Ratio | 41 | |||||
Price-to-Owner-Earnings | 38.34 | |||||
PEG Ratio | 2.12 | |||||
PS Ratio | 4.63 | |||||
PB Ratio | 4.8 | |||||
Price-to-Tangible-Book | 30.21 | |||||
Price-to-Free-Cash-Flow | 36.91 | |||||
Price-to-Operating-Cash-Flow | 25.72 | |||||
EV-to-EBIT | 27.45 | |||||
EV-to-Forward-EBIT | 20.87 | |||||
EV-to-EBITDA | 19.45 | |||||
EV-to-Forward-EBITDA | 18.09 | |||||
EV-to-Revenue | 4.83 | |||||
EV-to-Forward-Revenue | 4.62 | |||||
EV-to-FCF | 38.3 | |||||
Price-to-Projected-FCF | 1.71 | |||||
Price-to-DCF (Earnings Based) | 0.91 | |||||
Price-to-DCF (FCF Based) | 1.93 | |||||
Price-to-Median-PS-Value | 1.14 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.97 | |||||
Price-to-Graham-Number | 5.86 | |||||
Earnings Yield (Greenblatt) % | 3.64 | |||||
FCF Yield % | 2.72 | |||||
Forward Rate of Return (Yacktman) % | 16.3 |